Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $7.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.13B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CORT | CORCEPT THERAPEUTICS INC | $7.58B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $4.89B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NAGE | NIAGEN BIOSCIENCE INC | $610.34M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SPRY | ARS PHARMACEUTICALS INC | $1.37B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GYRE | GYRE THERAPEUTICS INC | $913.66M | N/A | 0.00% | $20.0200 | N/A | N/A | 0 | ||
| ARGX | ARGENX SE | $39.20B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.95B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.69B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $1.90B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $10.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SRPT | SAREPTA THERAPEUTICS INC | $6.05B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $7.56B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $349.40M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $18.92B | 1.31% | 43.80% | $0.2200 | $0.43 | 27% | 0 | 2025-05-16 | 2025-06-10 |
| NVO | NOVO NORDISK A S | $296.70B | 2.43% | 45.50% | $1.0992 | $1.61 | 52% | 9 | ||
| MDXG | MIMEDX GROUP INC | $1.01B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ADMA | ADMA BIOLOGICS INC | $5.66B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $12.13B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MNKD | MANNKIND CORP | $1.53B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCYT | VERACYTE INC | $2.38B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GNFT | GENFIT SA | $204.73M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.10B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $7.96B | 0.64% | 32.00% | $0.0800 | $0.32 | 11% | 1 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $2.44B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GMAB | GENMAB A | $14.00B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| UTHR | UNITED THERAPEUTICS CORP | $13.67B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| REGN | REGENERON PHARMACEUTICALS INC | $64.65B | 0.15% | 2.10% | $0.8800 | $0.88 | 1% | 0 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.